Literature DB >> 7504888

Keratin 17 expression as a marker for epithelial transformation in viral warts.

C M Proby1, L Churchill, P E Purkis, M T Glover, C J Sexton, I M Leigh.   

Abstract

The profile of keratin expression in benign warts from various cutaneous and mucosal sites along with dysplastic warts and squamous cell carcinomas has been examined using a panel of monospecific antibodies to epithelial keratins. Viral warts and verrucous keratoses from immunosuppressed renal transplant recipients show a spectrum of squamous atypia from benign lesions, from minimal changes to full thickness dysplasia. Changes associated with malignancy include loss of differentiation-specific keratins 1 and 10 together with expansion of basal cell epitopes and inappropriate expression of simple epithelial keratins 8, 18, and 19 in advanced squamous cell carcinoma. This late expression of keratins 8 and 18 contrasts with early expression of keratin 17 in all dysplastic lesions examined. Keratin 17 is found suprabasally in hyperproliferative lesions, including benign warts, but marked basal plus suprabasal expression is seen increasingly in malignantly transformed epidermis. These findings were not specific to immunosuppression, as shown by identical findings in control squamous cell carcinoma from nonimmunosuppressed individuals. Keratin 17 expression may prove prognostically helpful when assessing dysplasia in epidermal tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504888      PMCID: PMC1887274     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

1.  Cultured epithelial cells of cornea, conjunctiva and skin: absence of marked intrinsic divergence of their differentiated states.

Authors:  T T Sun; H Green
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

2.  Immunofluorescent staining of keratin fibers in cultured cells.

Authors:  T T Sun; H Green
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

Review 3.  Malignancies associated with immunosuppressive or cytotoxic therapy.

Authors:  I Penn
Journal:  Surgery       Date:  1978-05       Impact factor: 3.982

4.  Primary malignancy in patients undergoing immunosuppression for renal transplantation.

Authors:  C F McKhann
Journal:  Transplantation       Date:  1969-08       Impact factor: 4.939

5.  Hospital inquiries.

Authors:  D A Spencer
Journal:  Br Med J       Date:  1978-09-16

6.  Cancer in renal allograft recipients in Australia and New Zealand.

Authors:  A G Sheil
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

7.  Incidence of skin carcinoma after renal transplantation.

Authors:  E O Hoxtell; J S Mandel; S S Murray; L M Schuman; R W Goltz
Journal:  Arch Dermatol       Date:  1977-04

8.  Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia.

Authors:  F Smedts; F Ramaekers; S Troyanovsky; M Pruszczynski; H Robben; B Lane; I Leigh; F Plantema; P Vooijs
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

9.  Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

Authors:  L J Kinlen; A G Sheil; J Peto; R Doll
Journal:  Br Med J       Date:  1979-12-08

10.  Measurement of cutaneous inflammatory reactions using a scanning laser-Doppler velocimeter.

Authors:  A G Quinn; J McLelland; T Essex; P M Farr
Journal:  Br J Dermatol       Date:  1991-07       Impact factor: 9.302

View more
  18 in total

1.  Immunolocalization of vimentin, keratin 17, Ki-67, involucrin, β-catenin and E-cadherin in cutaneous squamous cell carcinoma.

Authors:  Yan-Ju Lan; Huan Chen; Jia-Qi Chen; Qiu-Hua Lei; Min Zheng; Zhe-Ren Shao
Journal:  Pathol Oncol Res       Date:  2013-09-04       Impact factor: 3.201

2.  Type I keratin 17 protein is phosphorylated on serine 44 by p90 ribosomal protein S6 kinase 1 (RSK1) in a growth- and stress-dependent fashion.

Authors:  Xiaoou Pan; Lesley A Kane; Jennifer E Van Eyk; Pierre A Coulombe
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

3.  Activated keratinocytes in the epidermis of hypertrophic scars.

Authors:  M Machesney; N Tidman; A Waseem; L Kirby; I Leigh
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18.

Authors:  Buse Cevatemre; Engin Ulukaya; Mehmet Sarimahmut; Arzu Yilmaztepe Oral; Fiona M Frame
Journal:  Tumour Biol       Date:  2015-04-07

5.  Differential keratin expression during epiboly in a wound model of bioengineered skin and in human chronic wounds.

Authors:  Su Luo; Tatyana Yufit; Polly Carson; David Fiore; Jane Falanga; Xiaofeng Lin; Lisa Mamakos; Vincent Falanga
Journal:  Int J Low Extrem Wounds       Date:  2011-08-19       Impact factor: 2.057

6.  Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma.

Authors:  P Maddox; P Sasieni; A Szarewski; M Anderson; A Hanby
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

7.  Topical vitamin A treatment of recalcitrant common warts.

Authors:  Anca Gaston; Robert F Garry
Journal:  Virol J       Date:  2012-01-17       Impact factor: 4.099

8.  Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins.

Authors:  Heidi Anderson-Dockter; Todd Clark; Satori Iwamoto; Ming Lu; David Fiore; Jane K Falanga; Vincent Falanga
Journal:  Dermatol Surg       Date:  2012-06-12       Impact factor: 3.398

9.  [Testosterone reduces the expression of keratinization-promoting genes in murine Meibomian glands].

Authors:  F Schirra; Z Gatzioufas; J Scheidt; B Seitz
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

10.  Keratin 17 null mice exhibit age- and strain-dependent alopecia.

Authors:  Kevin M McGowan; Xuemei Tong; Emma Colucci-Guyon; Francina Langa; Charles Babinet; Pierre A Coulombe
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.